2024-11-20 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**1. Performance Comparison and Divergence:**

Intuitive Surgical Inc. (ISRG) is a company that manufactures and sells da Vinci surgical systems and related instruments and accessories.  Over the period analyzed, ISRG significantly outperformed the S&P 500 (VOO).  The cumulative return for ISRG is 328.32%, while the S&P 500's cumulative return is 124.78%.  This results in a difference of 203.54%, placing it at the 98.63rd percentile of its historical range of outperformance against the S&P 500 (relative divergence).  The maximum historical outperformance was 206.5% and minimum was -10.27%.

**Alpha and Beta Analysis:**  The provided data shows consistently high alpha values (ranging from 0.8 to 1.4), indicating that ISRG has significantly outperformed its benchmark over various periods.  The beta values generally hover around 1.2, suggesting a moderate level of correlation with the overall market.  However, there is some variation, indicating sensitivity to market conditions.  The market capitalization has increased substantially over time.

| Year       | CAGR     | MDD  | Alpha | Beta | Cap(B) |
|------------|----------|------|-------|------|-------|
| 2015-2017  | 108.3%   | 12.5% | 69.9% | 0.8   | 43.3   |
| 2016-2018  | 162.5%   | 23.1% | 130.2%| 1.2   | 56.9   |
| 2017-2019  | 176.3%   | 23.1% | 124.6%| 1.4   | 70.2   |
| 2018-2020  | 118.0%   | 40.1% | 70.7% | 1.2   | 97.1   |
| 2019-2021  | 131.3%   | 40.1% | 31.3% | 1.2   | 128.0  |
| 2020-2022  | 33.3%    | 47.6% | 9.7%  | 1.2   | 94.5   |
| 2021-2023  | 26.5%    | 47.6% | -8.4% | 1.4   | 120.2  |
| 2022-2024  | 47.7%    | 47.0% | 19.2% | 1.3   | 187.9  |


**2. Recent Price Movement:**

* **Closing Price:** 531.64 (Last market: 536.44)
* **5-Day Moving Average:** 534.16
* **20-Day Moving Average:** 520.48
* **60-Day Moving Average:** 497.22

The price is currently above all three moving averages, suggesting upward momentum.  However, the recent closing price is slightly below the last market price suggesting a minor pullback.

**3. Technical Indicators:**

* **RSI (62.2):**  Indicates the stock is neither overbought nor oversold, suggesting a neutral condition.
* **PPO (0.07):**  A positive value suggests upward momentum, though relatively weak.
* **20-Day Relative Divergence (-0.65):** Shows a recent short-term decline in relative strength.

Given that 536.44 is only slightly higher than the closing price of 531.64, no significant sudden price movements (sharp uptrend or downtrend) are evident.  The expected return of 2.29% represents the projected long-term (2+ years) excess return over the S&P 500, assuming continued outperformance.

**4. Recent Financial Performance:**

The provided earnings data shows a generally increasing trend in both EPS and revenue, though some quarter-to-quarter fluctuations exist.  More detailed analysis would require comparison with analyst estimates for the reported periods.  Note that the 2024-10-18 entry is duplicated in the data.

| Date       | EPS  | Revenue    |
|------------|------|------------|
| 2024-10-18 | 1.59 | $2.04 B    |
| 2024-07-19 | 1.48 | $2.01 B    |
| 2024-04-19 | 1.54 | $1.89 B    |
| 2023-10-20 | 1.18 | $1.74 B    |
| 2024-10-18 | 1.18 | $1.74 B    |


**5.  Financial Information:**

* **Revenue and Profitability:** Shows consistent and high profit margins, demonstrating strong revenue generation and efficiency. Revenue appears to be growing.
* **Capital and Profitability:** Return on Equity (ROE) fluctuates but generally maintains a healthy level, indicating effective use of shareholder capital.

**6. News and Recent Issues:**

_(This section requires access to real-time news sources like Shacknews and Finbold.  Please provide specific news articles or links for a detailed analysis.)_  I need current information to analyze recent earnings news, market outlook, analyst opinions, and performance highlights.


**7. Overall Analysis:**

ISRG has demonstrated a strong historical performance significantly outperforming the S&P 500. While recent short-term indicators suggest a minor pullback, the long-term outlook remains positive given consistently high profit margins, growing revenue, and positive long-term return expectations.  However, a thorough analysis of recent news, analyst estimates, and any potential market risks is crucial before making any investment decisions. The consistent high alpha suggests strong potential for continued outperformance, but this is not guaranteed.  Further research into current market conditions and the competitive landscape of the medical device industry is advised.


**8. Disclaimer:** This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be based on thorough research and consideration of personal risk tolerance.
